Hosted by the European Organisation for Research and Treatment of Cancer, the National Cancer Institute, and the American Association for Cancer Research, the 2012 Symposium on Molecular Targets and Cancer Therapeutics will bring together more than 2,000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.
During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomized, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information. For these reasons, the symposium has been organized to ensure the maximum amount of interaction and discussion through an exciting range of plenary sessions and lively workshops. We hope that you will join us at this unique platform in Dublin and strengthen your links in the world of translational research.